QuickView for Transforming protein C-ets (biogroup)

1. L1000 CMAP - Breast carcinoma BT20 cells treated with ligand perturbagens
2. L1000 CMAP Osteosarcoma U-2 OS cells with gene overexpression perturbations
3. The Immunological Genome Project - Immune cell lineage differentiation and maturation
4. L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
5. L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens

There were no matches for Transforming protein C-ets

1. Efficacy and Safety of Zanubrutinib Plus Tislelizumab for Treatment of Patients With Richter Transfo…
2. Acalabrutinib, Venetoclax and Durvalumab for the Treatment of Richter Transformation From Chronic Ly…
3. Asian Phase II Study of INC424 in Patients With Primary Myelofibrosis (MF), Post-PV MF or Post-ET MF
4. Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Es…
5. Clinical Study of Partially Hydrolysed Protein Infant Formula on Trans-epidermal Water Loss (TEWL)